Duchesnay Summarizes Comprehensive Body of Evidence for Most Studied Morning Sickness Drug Worldwide – Over 40 years of clinical experience, 16 cohort studies, two meta-analyses support regulatory approvals and guidelines – Read more >
Duchesnay donates $12,000 to Moisson Laurentides, surpassing our 2015 contribution of $10,000 Read more >
Duchesnay Launches New Formulation of its Pregvit® and Pregvit® Folic 5 Prenatal Vitamins Read more >
Duchesnay obtains exclusive canadian commercial rights to Fluomizin™, indicated for the treatment of vaginal infections Read more >
